Giuseppe Mc Rosano,Cristiana Vitale,Petar Seferovic
Giuseppe Mc Rosano
Diabetes and heart failure are closely related: patients with diabetes have an increased risk of developing heart failure and those with heart failure are at higher risk of developing diabetes. Furthermore, antidiabetic medications increase...
Chronic Heart Failure Care Planning: Considerations in Older Patients [0.03%]
慢性心力衰竭的护理规划：老年患者中的考虑因素
Eilidh Hill,Jackie Taylor
Eilidh Hill
In developed countries, it is estimated that more than 10 % of adults aged over 70 years have heart failure (HF). Despite therapeutic advances, it remains a condition associated with significant morbidity and mortality. It is one of the com...
Practical Applications for Single Pill Combinations in the Cardiovascular Continuum [0.03%]
心血管病全程单片联合治疗的实践应用
Ferdinando Iellamo,Karl Werdan,Krzysztof Narkiewicz et al.
Ferdinando Iellamo et al.
Despite the availability of new drugs and devices, the treatment of cardiovascular disease remains suboptimal. Single-pill combination therapy offers a number of potential advantages. It can combine different classes of drugs to increase ef...
How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders [0.03%]
如何通过钾结合剂改善挽救心力衰竭患者生命的治疗依从性
Mitja Lainscak
Mitja Lainscak
Medications that affect the renin-angiotensin-aldosterone system (RAAS) form the mainstay of current heart failure (HF) therapy in patients with reduced ejection fraction. Concerns about the risk of hyperkalaemia have created a significant ...
John J Atherton,Annabel Hickey
John J Atherton
Large-scale randomised controlled trials (RCTs) have demonstrated that angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and beta-blockers decrease mortality and hospitalisation in patients with heart failure (HF) asso...
Thomas G von Lueder,Dipak Kotecha,Dan Atar et al.
Thomas G von Lueder et al.
A key feature of chronic heart failure (HF) is the sustained activation of endogenous neurohormonal systems in response to impaired cardiac pumping and/or filling properties. The clinical use of neurohormonal blockers has revolutionised the...
Julio A Chirinos,Nancy Sweitzer
Julio A Chirinos
Measures of interaction between the left ventricle (LV) and arterial system (ventricular-arterial coupling) are important but under-recognised cardiovascular phenotypes in heart failure. Ventriculo-arterial coupling is commonly assessed in ...
Gianluigi Savarese,Lars H Lund
Gianluigi Savarese
Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is increasing in prevalence. HF health expenditures are considerable and will increase dramatically with an ageing population. Despite the significan...
Andrew Js Coats,Giuseppe Rosano
Andrew Js Coats
Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? [0.03%]
β受体阻滞剂与伊伐布雷定联合治疗慢性心力衰竭患者的一项新的治疗选择？
Maurizio Volterrani,Ferdinando Iellamo
Maurizio Volterrani
While substantial advances have been made in the treatment of chronic heart failure (CHF) in the past decade, the prevalence of CHF is increasing. CHF represents a growing financial burden on healthcare systems and, despite therapeutic adva...